Asthma in children that is poorly controlled more than doubles the cost of treating it and hurts their school performance, U.S. researchers say. Dr. Stanley Szefler, a professor of pediatrics at National Jewish Health who led the study, and colleagues studied 628 children ages 6-12 with severe or difficult-to-treat asthma. The researchers evaluated direct medical costs -- medications, unscheduled office and emergency visits, and hospital admissions -- and indirect costs such as school days lost. Costs were evaluated at baseline, 12 months and 24 months. Patients were divided into three groups -- very poorly controlled, not well-controlled and well-controlled asthma, using National Institute of Health guidelines. Very poorly controlled asthma patients incurred at baseline an average of $7,846 in costs associated with asthma, compared with $3,526 for not well controlled asthma patients and $3,766 for well-controlled asthma. Two years later, costs for very poorly controlled asthma patients increased to $8,880 while costs for those with well-controlled asthma dropped to $1,861. All costs are in 2002 dollars and costs in 2011 dollars would be about 25 percent greater, the researchers say. The study, published in The Archives of Allergy, Asthma & Immunology, finds children with very poorly controlled asthma finds missed an average of 18 days of school each year, compared with two or less for other asthma patients.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor